2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases | Zendy

Mei Shao | Zendy; Jinhua Zi | Zendy; Guanghua Wen | Zendy

Open Access

2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases

Author(s) -

Mei Shao,

Jinhua Zi,

Guanghua Wen

Publication year - 2017

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.207069

Subject(s) - medicine , breast cancer , positron emission tomography , magnetic resonance imaging , radiology , lymph node , mammography , nuclear medicine , breast mri , biopsy , breast carcinoma , cancer

Proper preoperative staging is vital in the treatment of breast cancer patients. Fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) and conventional diagnostic modalities including ultrasonography (US), mammography (MG), and magnetic resonance imaging (MRI) play a greater role.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research